63432 Baseline Itch Severity and Time to First Initiation of Therapy with a Biologic in Patients with Moderate or Severe Atopic Dermatitis: a Retrospective Cohort Study of a Population Treated between 2022 and 2024 in Private Specialty Dermatology Practices acr

Journal article

Peer reviewed

Gil Yosipovitch, Matthew Zirwas, Lawrence Rasouliyan, Amanda G. Althoff, Danae A. Black, Lorenzo Sabatelli and Peter Lio

Journal of the American Academy of Dermatology, Vol.93(3), pp.AB132-AB132

2025-09

Metrics

1 Record Views

Title: 63432 Baseline Itch Severity and Time to First Initiation of Therapy with a Biologic in Patients with Moderate or Severe Atopic Dermatitis: a Retrospective Cohort Study of a Population Treated between 2022 and 2024 in Private Specialty Dermatology Practices acr
Creators: Gil Yosipovitch - University of Miami
Matthew Zirwas - Bexley Dermatology Research Clinic, Bexley, OH, US
Lawrence Rasouliyan - OMNY Health, Atlanta, GA, USA
Amanda G. Althoff - OMNY Health, Atlanta, GA, USA
Danae A. Black - OMNY Health, Atlanta, GA, USA
Lorenzo Sabatelli - Galderma, Zug, Switzerland
Peter Lio - Medical Dermatology Associates of Chicago, Chicago, IL, USA
Publication Details: Journal of the American Academy of Dermatology, Vol.93(3), pp.AB132-AB132
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Dermatology & Cutaneous Surgery
Language: English
Resource Type: Journal article
Record Identifier: 991032730089002976